Baseline clinical characteristics and medications at the time of follow-up between patients with and without in-stent restenosis.

ACE, angiotensin-converting enzyme; ARB, angiotensin-receptor blocker; ECG, electrocardiography; HDL, high density lipoprotein; hsCRP, high-sensitivity C-reactive protein; LDL, low density lipoprotein; LV, left ventricular; MI, myocardial infarction; NSTEMI, non-ST-segment elevation myocardial infarction; RWMA, regional wall motion abnormality; STEMI, ST-segment elevation myocardial infarctionBaseline clinical characteristics and medications at the time of follow-up between patients with and without in-stent restenosis.